Analysis of VTE Multiple Risk Factors and Active Prevention in High Risk Group

  • Wei Ni
DOI: https://doi.org/10.18686/aem.v4i2.54
Keywords: Venous thrombosis, Risk factors, Primary prevention

Abstract

Deeper understanding of venous thrombosis’s risk factors and pathogenesis for patients at high risk group and the patient would be informed the disease risk and be advised of the need to improve the way of life. Strengthening of the hospitalized patients with VTE multiple risk factors for risk assessment and the active prevention are effective in reducing the morbidity and mortality rate of VTE.

References

1. Douketis JD, Gu CS, Schulman S, et. al. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med. 2007;147(11):766‒774.
2. Esmon CT. Basic mechanisms and pathogenesis of venousthrombosis. Blood Rev. 2009;23(5):225‒229.
3. Stein PD, Patel KC, Kalra NK, et al. Deep venoas thrombosis in a General hospital. Chest. 2002;122(3):960‒962.
4. Heit JA. Venous thromboembolism：disease burden, outcomes and risk factors. Thromb Haemost. 2005;3(8):1611‒1617.
5. Martinelli I, BucciareUi P, Passamonti SM, et al. Longterm evaluation of the risk cerebral sinus-venous thrombosis. Circulation. 2010;121(25):2740‒2746.
6. Lussana F, Dentali F, Ageno, et al. Venous thrombosis at unusual sites and the role of thrombophilia. Semin Thromb Hemost. 2007;33(6):582‒587.
7. Eischer L, Eichinger S, Kyrle PA. Age at first venousthromboembolism and risk of recurrence:a prospectivecohort study. Medicine(Baltimore). 2009;88(6):366‒370.
8. West J, Perrin K, Aldington S, et al. A case-control Study of seated immobility at work as a risk factor for venous thmmboembolism. JR Soc Med. 2008;101(5):237‒243.
9. Zhang LM, Tang HY, Pi HY, et al. Risk factors of deep venous thrombosis after joint replacement. Nursing research. 2007; 21(10):2564‒2567.
10. Martha LL, Alejandro LL, Vi D, et.al. Development of a clinical Prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism. Blood. 2010;12(06):304‒306.
11. Li F, Li GH, Chen C, et al. Effects of anesthesia on deep venous thrombosis after total hip arthroplasty. Chinese Journal of Orthopaedic Surgery. 2003;11(21):1‒2.
12. Prandoni P. Acquired risk factors for venous thromboembolism in medical patients. Hematology Am Soc Hematol Educ Program. 2005;458‒461.
13. Clayton TC, Gaskin M, Meade TW. Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database. Int J Epidemiol. 2011;21(5):254‒256.
14. Matta F, Singala R, Yaekoub AY, et al. Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost. 2009;101(1):134‒138.
15. Zan YT, Mohan, Huang X, et al. Study on the correlation between anticardiolipin antibody positive patients with risk factors for thrombosis. Thrombosis and Haemostasis Journal. 2006;12(6):252‒253.
16. Matta F, Yaekoub AY, Stein PD, et al. Human immunedeficiency virus infection and risk of venous thromboembolism. Am J Med Sci. 2008;336(5):402‒406.
17. Bennett CL, Sehumock GT, Desai AA, et al. Thalidomide-associated deep vein thrombosis and pulmonary embolism. Am J Med. 2002;l13(7):603‒606.
18. Wang, Jun PH, Leaf W. Thalidomide in patients with hematologic malignancies induced thrombosis effect of preliminary inquiry. Thrombosis and Hemostasis. 2010;16(3):124‒126.
19. Parker C, Coupland C, Hippisley-Cox J. Antipsyehotic drugs and risk of venous thromboembolism: nested case control study. BMJ. 2010;341(4):245‒255.
20. Lai S, Xu F. Clinical analysis of deep venous thrombosis (ICU) in 32 cases. Journal of Medical University of Chongqing. 2009;34(4):511‒509.
21. Li X. The risk of deep venous thromboembolism in patients with deep venous thrombosis in department of internal medicine. Chinese Journal of Cardiovascular and cerebrovascular diseases. 2009;11:901‒902.
22. Naeearato M, Chiodo GF, Dennis M, et al. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev. 2010;4(8):19‒22.
Published
2015-04-27
Issue
Vol 4 No 2 (2015)
Section
Original Research Article

Copyright (c) 2015 Wei Ni

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear

Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.